WNT and NOTCH Signaling Pathways As Activators for Epidermal Growth Factor Receptor in Esophageal Squamous Cell Carcinoma

Overview

Journal Cell Mol Biol Lett

Publisher Biomed Central

Specialties Biochemistry
Cell Biology
Molecular Biology

Date 2018 Sep 12

PMID 30202417

Citations 26

Authors

Mohammad Reza Abbaszadegan

Anali Riahi

Mohammad Mahdi Forghanifard

Meysam Moghbeli

Affiliations

Soon will be listed here.

Abstract

Background: Esophageal squamous cell carcinoma (ESCC) is the most common histological type of esophageal cancer, with a poor prognosis. Deregulation of WNT and NOTCH signaling pathways is important in ESCC progression, which can be due to either malfunction of their components or crosstalk with other pathways. Therefore, identification of new crosstalk between such pathways may be effective to introduce new strategies for targeted therapy of cancer. A correlation study was performed to assess the probable interaction between growth factor receptors and WNT/NOTCH pathways via the epidermal growth factor receptor (EGFR) and Musashi1 (MSI1), respectively.

Methods: Levels of MSI1/EGFR mRNA expression in tumor tissues from 48 ESCC patients were compared to their corresponding normal tissues using real-time polymerase chain reaction.

Results: There was a significant correlation between EGFR and MSI1 expression ( = 0.05). Moreover, there was a significant correlation between EGFR/MSI1 expression and grade of tumor differentiation ( = 0.02).

Conclusion: This study confirms a direct correlation between MSI1 and EGFR and may support the important role of MSI1 in activation of EGFR through NOTCH/WNT pathways in ESCC.

Citing Articles

Research Progress of Liquid Biopsy Based on DNA Methylation in Tumor Diagnosis and Treatment.

Bao Y, Wang X, Zeng B, Shi Y, Huang Y, Huang Y Biomolecules. 2025; 14(12.

PMID: 39766341 PMC: 11727523. DOI: 10.3390/biom14121634.

Prognostic value of ubiquitination-related differentially expressed genes in esophageal squamous cell carcinoma: a comprehensive analysis and future directions.

Chen J, Zhang Y, Lin Z, Peng Y, Madan A, Cai S J Thorac Dis. 2024; 16(11):7866-7884.

PMID: 39678832 PMC: 11635202. DOI: 10.21037/jtd-24-1863.

Transcriptome profiling and analysis of patients with esophageal squamous cell carcinoma from Kazakhstan.

Sharip A, Rakhimova S, Molkenov A, Ashenova A, Kozhamkulov U, Akhmetollayev I Front Genet. 2024; 15:1249751.

PMID: 38562378 PMC: 10982404. DOI: 10.3389/fgene.2024.1249751.

PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells.

Navaei Z, Khalili-Tanha G, Zangouei A, Abbaszadegan M, Moghbeli M Oncol Res. 2023; 29(4):235-250.

PMID: 37303943 PMC: 10208004. DOI: 10.32604/or.2022.025323.

MicroRNA-506 as a tumor suppressor in anaplastic thyroid carcinoma by regulation of WNT and NOTCH signaling pathways.

Navaei Z, Taghehchian N, Zangouei A, Abbaszadegan M, Moghbeli M Iran J Basic Med Sci. 2023; 26(5):594-602.

PMID: 37051101 PMC: 10083834. DOI: 10.22038/IJBMS.2023.69174.15069.

References

Cattaneo F, Iaccio A, Guerra G, Montagnani S, Ammendola R . NADPH-oxidase-dependent reactive oxygen species mediate EGFR transactivation by FPRL1 in WKYMVm-stimulated human lung cancer cells. Free Radic Biol Med. 2011; 51(6):1126-36. DOI: 10.1016/j.freeradbiomed.2011.05.040. View

Miele L . Notch signaling. Clin Cancer Res. 2006; 12(4):1074-9. DOI: 10.1158/1078-0432.CCR-05-2570. View

Nikpour P, Baygi M, Steinhoff C, Hader C, Luca A, Mowla S . The RNA binding protein Musashi1 regulates apoptosis, gene expression and stress granule formation in urothelial carcinoma cells. J Cell Mol Med. 2010; 15(5):1210-24. PMC: 3822633. DOI: 10.1111/j.1582-4934.2010.01090.x. View

Ciardiello F, Tortora G . Epidermal growth factor receptor (EGFR) as a target in cancer therapy: understanding the role of receptor expression and other molecular determinants that could influence the response to anti-EGFR drugs. Eur J Cancer. 2003; 39(10):1348-54. DOI: 10.1016/s0959-8049(03)00235-1. View

Okano H, Kawahara H, Toriya M, Nakao K, Shibata S, Imai T . Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res. 2005; 306(2):349-56. DOI: 10.1016/j.yexcr.2005.02.021. View

Anido J, Matar P, Albanell J, Guzman M, Rojo F, Arribas J . ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. Clin Cancer Res. 2003; 9(4):1274-83. View

DiPetrillo T, Suntharalingam M, Ng T, Fontaine J, Horiba N, Oldenburg N . Neoadjuvant paclitaxel poliglumex, cisplatin, and radiation for esophageal cancer: a phase 2 trial. Am J Clin Oncol. 2011; 35(1):64-7. DOI: 10.1097/COC.0b013e318201a126. View

Bobryshev Y, Freeman A, Botelho N, Tran D, Levert-Mignon A, Lord R . Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma. Dis Esophagus. 2010; 23(7):580-9. DOI: 10.1111/j.1442-2050.2010.01061.x. View

Hanawa M, Suzuki S, Dobashi Y, Yamane T, Kono K, Enomoto N . EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer. 2005; 118(5):1173-80. DOI: 10.1002/ijc.21454. View

10.

Moghbeli M, Sadrizadeh A, Forghanifard M, Mozaffari H, Golmakani E, Abbaszadegan M . Role of Msi1 and PYGO2 in esophageal squamous cell carcinoma depth of invasion. J Cell Commun Signal. 2015; 10(1):49-53. PMC: 4850136. DOI: 10.1007/s12079-015-0314-6. View

11.

Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo J, Ranganathan S . Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology. 2005; 129(1):285-302. PMC: 1821080. DOI: 10.1053/j.gastro.2005.04.013. View

12.

Yang Y, Xu K, Zhou Y, Gao X, Chen L . Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas. Chin Med J (Engl). 2012; 125(3):450-4. View

13.

Wang X, Zhang S, MacLennan G, Eble J, Lopez-Beltran A, Yang X . Epidermal growth factor receptor protein expression and gene amplification in small cell carcinoma of the urinary bladder. Clin Cancer Res. 2007; 13(3):953-7. DOI: 10.1158/1078-0432.CCR-06-2167. View

14.

Kamangar F, Dores G, Anderson W . Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24(14):2137-50. DOI: 10.1200/JCO.2005.05.2308. View

15.

Tveteraas I, Muller K, Aasrum M, Odegard J, Dajani O, Guren T . Mechanisms involved in PGE2-induced transactivation of the epidermal growth factor receptor in MH1C1 hepatocarcinoma cells. J Exp Clin Cancer Res. 2012; 31:72. PMC: 3542006. DOI: 10.1186/1756-9966-31-72. View

16.

Moghbeli M, Abbaszadegan M, Golmakani E, Forghanifard M . Correlation of Wnt and NOTCH pathways in esophageal squamous cell carcinoma. J Cell Commun Signal. 2016; 10(2):129-35. PMC: 4882302. DOI: 10.1007/s12079-016-0320-3. View

17.

Kawahara H, Imai T, Imataka H, Tsujimoto M, Matsumoto K, Okano H . Neural RNA-binding protein Musashi1 inhibits translation initiation by competing with eIF4G for PABP. J Cell Biol. 2008; 181(4):639-53. PMC: 2386104. DOI: 10.1083/jcb.200708004. View

18.

Ji H, Wang J, Nika H, Hawke D, Keezer S, Ge Q . EGF-induced ERK activation promotes CK2-mediated disassociation of alpha-Catenin from beta-Catenin and transactivation of beta-Catenin. Mol Cell. 2009; 36(4):547-59. PMC: 2784926. DOI: 10.1016/j.molcel.2009.09.034. View

19.

Moghbeli M, Forghanifard M, Sadrizadeh A, Mozaffari H, Golmakani E, Abbaszadegan M . Role of Msi1 and MAML1 in Regulation of Notch Signaling Pathway in Patients with Esophageal Squamous Cell Carcinoma. J Gastrointest Cancer. 2015; 46(4):365-9. DOI: 10.1007/s12029-015-9753-9. View

20.

Zajac M, Law J, Cvetkovic D, Pampillo M, McColl L, Pape C . GPR54 (KISS1R) transactivates EGFR to promote breast cancer cell invasiveness. PLoS One. 2011; 6(6):e21599. PMC: 3125256. DOI: 10.1371/journal.pone.0021599. View